Skip to main content

Advertisement

Log in

Short-Term Effects of Ankaferd Hemostat for Renal Artery Embolization: An Experimental Study

  • Laboratory Investigation
  • Published:
CardioVascular and Interventional Radiology Aims and scope Submit manuscript

Abstract

Purpose

Renal artery embolization (RAE) is a minimally invasive therapeutic technique that is utilized in a number of disorders. Ankaferd is a novel hemostatic agent with a new mechanism of action independent of clotting factors. We used Ankaferd for RAE in a sheep model.

Methods

Seven adult female sheep were included in the study. Selective renal arteriogram using 5-F diagnostic catheter was performed to make sure that each kidney was fed by a single renal artery and the animal had normal renal vasculature. Coaxial 2.7-F microcatheter was advanced to the distal main renal artery. Under fluoroscopic guidance, 2 mL of Ankaferd mixed with 2 mL of nonionic iodinated contrast agent was slowly injected. Fluoroscopy was used to observe the deceleration of flow and stagnation. Control renal angiograms were performed just after embolization. After the procedure, the animals were observed for 1 day and then sacrificed with intravenous sodium thiopental.

Results

The technical success was observed in seven of the seven animals.. After embolization procedure, none of the animals died or experienced a major systemic adverse event. On macroscopic examination of the embolized kidneys, thrombus at the level of main renal artery formed after Ankaferd embolization was more compact compared with the thrombi that was not Ankaferd-associated, which was observed elsewhere. Microscopically, majority of the renal tubular cells (80–90 %) were necrotic, and there was epithelial cell damage in a small portion of the cells (10–20 %).

Conclusions

RAE was safe and effective in the short-term with Ankaferd in studied animals. Further studies should be conducted to better delineate the embolizing potential of this novel hemostatic agent.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. NIH Publication No. 80–23 (revised 1985)

  2. Bendszus M, Klein R, Burger R, Warmuth-Metz M, Hofmann E, Solymosi L (2000) Efficacy of trisacryl gelatin microspheres versus polyvinyl alcohol particles in the preoperative embolization of meningiomas. AJNR Am J Neuroradiol 21(2):255–261

    PubMed  CAS  Google Scholar 

  3. Beyazit Y, Kurt M, Kekilli M, Goker H, Haznedaroglu IC (2010) Evaluation of hemostatic effects of Ankaferd as an alternative medicine. Altern Med Rev 15(4):329–336

    PubMed  Google Scholar 

  4. Derdeyn CP, Graves VB, Salamat MS, Rappe A (1997) Collagen-coated acrylic microspheres for embolotherapy: in vivo and in vitro characteristics. AJNR Am J Neuroradiol 18(4):647–653

    PubMed  CAS  Google Scholar 

  5. el-Nahas AR, Shokeir AA, Mohsen T et al (2008) Functional and morphological effects of postpercutaneous nephrolithotomy superselective renal angiographic embolization. Urology 71(3):408–412

    Article  PubMed  Google Scholar 

  6. Ercetin S, Kurt M et al (2010) Safety and efficacy of Ankaferd Blood Stopper in dental surgery. Int J Hematol Oncol 20:1–5

    Article  Google Scholar 

  7. Ergenoglu MU, Yerebakan H, Kucukaksu DS (2010) A new practical alternative for the control of sternal bleeding during cardiac surgery: Ankaferd Blood Stopper. Heart Surg Forum 13(6):E379–E380

    Article  PubMed  Google Scholar 

  8. Fan CM (1999) Transcatheter renal artery embolization: indications and technical considerations. Tech Vasc Interv Radiol 2:114–122

    Article  Google Scholar 

  9. Ginat DT, Saad WE, Turba UC (2009) Transcatheter renal artery embolization: clinical applications and techniques. Tech Vasc Interv Radiol 12(4):224–239

    Article  PubMed  Google Scholar 

  10. Goker H, Haznedaroglu IC, Ercetin S et al (2008) Haemostatic actions of the folkloric medicinal plant extract Ankaferd Blood Stopper. J Int Med Res 36(1):163–170

    PubMed  CAS  Google Scholar 

  11. Guler M, Maralcan G, Kul S, Baskonus I, Yilmaz M (2011) The efficacy of Ankaferd Blood Stopper for the management of bleeding following total thyroidectomy. J Invest Surg 24(5):205–210

    Article  PubMed  Google Scholar 

  12. Han YM, Bjarnason H, Gu X et al (2001) Renal artery embolization with diluted hot contrast medium: an experimental study. J Vasc Interv Radiol 12(7):862–868

    Article  PubMed  CAS  Google Scholar 

  13. Haznedaroglu BZ, Beyazit Y, Walker SL, Haznedaroglu IC (2011) Pleiotropic cellular, hemostatic, and biological actions of Ankaferd hemostat. Crit Rev Oncol Hematol (in press)

  14. Hom D, Eiley D, Lumerman JH, Siegel DN, Goldfischer ER, Smith AD (1999) Complete renal embolization as an alternative to nephrectomy. J Urol 161(1):24–27

    Article  PubMed  CAS  Google Scholar 

  15. Hotaling JM, Sorensen MD, Smith TG 3rd, Rivara FP, Wessells H, Voelzke BB (2011) Analysis of diagnostic angiography and angioembolization in the acute management of renal trauma using a national data set. J Urol 185(4):1316–1320

    Article  PubMed  Google Scholar 

  16. Huri E, Akgul T, Ayyildiz A, Ustun H, Germiyanoglu C (2009) Hemostatic role of a folkloric medicinal plant extract in a rat partial nephrectomy model: controlled experimental trial. J Urol 181(5):2349–2354

    Article  PubMed  Google Scholar 

  17. Huri E, Akgul KT, Yucel MO, Astarci HM, Ustun H, Germiyanoglu RC (2011) The second step in vitro trial of Ankaferd® Bloodstopper®: comparison with other hemostatic agents. Turk J Med Sci 41:15–17

    Google Scholar 

  18. Iynen I, Sogut O, Kose R (2011) The efficacy of Ankaferd Blood Stopper in heparin-induced hemostatic abnormality in a rat epistaxis model. Otolaryngol Head Neck Surg. 145(5):840–844

    Article  PubMed  Google Scholar 

  19. Keller FS, Coyle M, Rosch J, Dotter CT (1986) Percutaneous renal ablation in patients with end-stage renal disease: alternative to surgical nephrectomy. Radiology 159(2):447–451

    PubMed  CAS  Google Scholar 

  20. Khankan AA, Osuga K, Hori S, Morii E, Murakami T, Nakamura H (2004) Embolic effects of superabsorbent polymer microspheres in rabbit renal model: comparison with tris-acryl gelatin microspheres and polyvinyl alcohol. Radiat Med 22(6):384–390

    PubMed  Google Scholar 

  21. Kilic O, Gonen M, Acar K et al (2010) Haemostatic role and histopathological effects of a new haemostatic agent in a rat bladder haemorrhage model: an experimental trial. BJU Int 105(12):1722–1725

    Article  PubMed  CAS  Google Scholar 

  22. Kurt M, Akdogan M, Ibis M, Haznedaroglu IC (2010) Ankaferd blood stopper for gastrointestinal bleeding. J Invest Surg 23(4):239

    Article  PubMed  Google Scholar 

  23. Meric Teker A, Korkut AY, Kahya V, Gedikli O (2010) Prospective, randomized, controlled clinical trial of Ankaferd Blood Stopper in patients with acute anterior epistaxis. Eur Arch Otorhinolaryngol 267(9):1377–1381

    Article  PubMed  Google Scholar 

  24. Ozaslan E, Purnak T, Yildiz A, Haznedaroglu IC (2010) The effect of a new hemostatic agent for difficult cases of non-variceal gastrointestinal bleeding: Ankaferd blood stopper. Hepatogastroenterology 57(98):191–194

    PubMed  Google Scholar 

  25. Ozaslan E, Purnak T, Haznedaroglu IC (2011) Ankaferd Blood Stopper in GI bleeding: alternative for everything? Gastrointest Endosc 73(1):185–186; author reply 186–187

    Google Scholar 

  26. Sam K, Gahide G, Soulez G et al (2011) Percutaneous embolization of iatrogenic arterial kidney injuries: safety, efficacy, and impact on blood pressure and renal function. J Vasc Interv Radiol 22(11):1563–1568

    Article  PubMed  Google Scholar 

  27. Senturk C, Cakir V, Yorukoglu K, Yilmaz O, Goktay AY (2010) Looking for the ideal particle: an experimental embolization study. Cardiovasc Interv Radiol 33(2):336–345

    Article  Google Scholar 

  28. Solak Y, Polat I, Atalay H, Turk S (2010) When urine is no longer beneficial: renal artery embolisation in severe nephrotic syndrome secondary to amyloidosis. Amyloid 17(1):24–26

    Article  PubMed  Google Scholar 

  29. Stampfl S, Bellemann N, Stampfl U et al (2008) Inflammation and recanalization of four different spherical embolization agents in the porcine kidney model. J Vasc Interv Radiol 19(4):577–586

    Article  PubMed  Google Scholar 

  30. Takebayashi S, Hosaka M, Kubota Y, Ishizuka E, Iwasaki A, Matsubara S (1998) Transarterial embolization and ablation of renal arteriovenous malformations: efficacy and damages in 30 patients with long-term followup. J Urol 159(3):696–701

    Article  PubMed  CAS  Google Scholar 

  31. Turhan N, Kurt M, Shorbagi A, Akdogan M, Haznedaroglu IC (2009) Topical Ankaferd Blood Stopper administration to bleeding gastrointestinal carcinomas decreases tumor vascularization. Am J Gastroenterol 104(11):2874–2877

    Article  PubMed  Google Scholar 

  32. Turhan NHB, Captug O, Kurt M, Shorbagi A, Beyazit Y, Kurt OK, Kosar A, Haznedaroglu IC (2011) Evaluation of a hemostatic agent in rabbits. Afr J Tradit Complement Altern Med 8(1):61–65

    PubMed  Google Scholar 

  33. Ubara Y, Tagami T, Sawa N et al (2002) Renal contraction therapy for enlarged polycystic kidneys by transcatheter arterial embolization in hemodialysis patients. Am J Kidney Dis 39(3):571–579

    Article  PubMed  Google Scholar 

Download references

Acknowledgment

The authors thank Genc Medical for financial support for the conduction of the study. Dr. A. Gaipov received grant support from the ERA-EDTA fellowship program.

Conflict of interest

All of the authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Orhan Ozbek.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ozbek, O., Acar, K., Koc, O. et al. Short-Term Effects of Ankaferd Hemostat for Renal Artery Embolization: An Experimental Study. Cardiovasc Intervent Radiol 36, 498–504 (2013). https://doi.org/10.1007/s00270-012-0419-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00270-012-0419-8

Keywords

Navigation